To determine the antiviral inhibitory activity and cytotoxicity of test molecules against respiratory viruses listed in one or more of the test groups below using the specified test method to identify…
Ended Awarded Last action
- Contract number
- 75N93021F00001
- Awardee
-
Utah State University UEI SPE2YDWHDYU4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $364,770
Award facts
- Contract value 80% obligated
-
- $364,770.00 Current, with exercised options
- $457,404.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Logan, UT 84322, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$63,980 | |
| Exercise an Option | $25,000 | |
| Original award | $403,750 |
About this award
This $457,404 firm fixed price delivery order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Utah State University, doing business as USU, on its In Vitro Assessments of Antimicrobial Activity master IDIQ contract vehicle. The order calls for USU to determine the antiviral inhibitory activity and cytotoxicity of test molecules against respiratory viruses using specified test methods, to identify active molecules for further investigation. The work will be performed in Logan, Utah over a one year period ending in May 2022. The National Institute of Allergy and Infectious Diseases supports research on infectious, immunologic and allergic diseases and is seeking new treatments through this in vitro screening of potential antiviral compounds by USU.
Description
To determine the antiviral inhibitory activity and cytotoxicity of test molecules against respiratory viruses listed in one or more of the test groups below using the specified test method to identify active test molecules for further investigation.
Quick answers
Who was awarded contract 75N93021F00001?
75N93021F00001 was awarded to Utah State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 3, 2021.
How much is contract 75N93021F00001 worth?
The government has obligated $364,770 on 75N93021F00001. Its potential value, with all options, is $457,404.
Is contract 75N93021F00001 an order under another contract?
Yes. 75N93021F00001 is a delivery order under 75N93019D00021, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93021F00001 competed?
The extent of competition for 75N93021F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award